ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Developing systemic & inhaled antibiotics for lung infections
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
The 6 meanings of “Lack of Access” (UNSLAP)
Non-traditional antibiotics: A pipeline review and an analysis of key development challenges
Lancet: 10-20-30 targets to address AMR by 2030
Push! Pull! Push! Pull! / Highlights from Davos 2018
Developing antibiotics for children: There are no easy answers
Lessons in Discovery from Lynn Silver + Pro-con on alternatives to antibiotics
De-risking vaccine development: Insights spanning decades of experience
New pipeline analysis: Cancer projects were funded 17x more than antibacterials during 2011-2020
DTR Gram-negative infections: Are new antibiotics making a difference?
FDA Workshop: Animal Models To Support Antibacterial Development (5 Mar 2020, post-meeting notes)
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet








